Jakub Mlodawski
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jakub Mlodawski has a total of 150 co-authors. Here are the top co-authors by number of shared publications:
- Marta Mlodawska
Collegium Medicum, Jan Kochanowski University, 25-369 Kielce, Poland
20 shared publications - Grzegorz Świercz
Collegium Medicum, Jan Kochanowski University in Kielce, 25-369 Kielce, Poland
13 shared publications Marta Mlodawska
Collegium Medicum, Jan Kochanowski Univeristy, Kielce, Poland
11 shared publications- Mirosław Wielgoś
Department of Obstetrics and Perinatology, National Medical Institute of the Ministry of the Interior and Administration, 02-507 Warsaw, Poland
9 shared publications - Piotr Laudanski
Department of Obstetrics, Gynecology and Gynecological Oncology, Medical University of Warsaw, 03-242 Warsaw, Poland
9 shared publications - Anna Zmelonek-Znamirowska
Collegium Medicum, Jan Kochanowski University in Kielce, 25-516 Kielce, Poland
8 shared publications
Latest Publications
- Open Access
- 15 November 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (22) , 8946
Predictors of Missing Outputs in AI-Based Fetal CNS Biometry Using SonoCNS: A Real-World Cohort Study
Background: Artificial intelligence (AI)-based automated fetal central nervous system (CNS) biometry using SonoCNS may streamline ultrasound assessment, but missing outputs occur in clinical practice. This study aimed to quantify the frequency and patterns of missing SonoCNS measurements across two separately acquired fetal head volumes and to investigate their associations with gestational age, operator, fetal presentation, and fetal biometric characteristics. Methods: This single-center retrospective secondary analysis used prospectively collected data from 385 women examined between 1 May 2022 and 31 May 2023. Each participant underwent second- or third-trimester ultrasound assessment with SonoCNS measurements obtained from two separately acquired volumes (a1, a2) for BPD, HC, OFD, cisterna magna (CM), lateral ventricular atrial width (Vp), and transverse cerebellar diameter (Cereb). Primary endpoints (full set: BPD/HC/OFD/CM/Vp/Cereb) were persistent AI failure (the same parameter missing in both acquisitions for at least one of the six parameters) and AI instability (missing ≥1 parameter in ≥1 acquisition). Structure-specific models assessed miss_CM, miss_Vp, and miss_Cereb. Logistic regression adjusted for operator, fetal presentation, gravidity/parity, and GA-adjusted fetal size residual z-scores (EFW-, HC-, and BPD-for-GA); sensitivity analyses were restricted to AZZ and to examinations at p < 0.001). In multivariable models, the corresponding adjusted ORs were 9.61 (95% CI 4.55–20.28), 9.62 (4.57–20.27), and 21.29 (10.25–44.22), respectively (all p < 0.001). These associations persisted in AZZ-only analyses. Examinations performed by JM were associated with lower CM/Cereb instability and persistent failure, although operator comparisons were limited by the absence of JM examinations at ≥28 weeks. Conclusions: Missing SonoCNS outputs were common across two acquisitions. Later gestational age was associated with greater output instability, particularly for lateral ventricular atrial width, but not with persistent failure after adjustment. Operator-associated differences were observed for selected endpoints; however, their interpretation is limited by the unequal gestational age distribution and the absence of objective acquisition-quality assessment.
- 15 November 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (22) , 8946
Open AccessPredictors of Missing Outputs in AI-Based Fetal CNS Biometry Using SonoCNS: A Real-World Cohort Study
Background: Artificial intelligence (AI)-based automated fetal central nervous system (CNS) biometry using SonoCNS may streamline ultrasound assessment, but missing outputs occur in clinical practice. This study aimed to quantify the frequency and patterns of missing SonoCNS measurements across two separately acquired fetal head volumes and to investigate their associations with gestational age, operator, fetal presentation, and fetal biometric characteristics. Methods: This single-center retrospective secondary analysis used prospectively collected data from 385 women examined between 1 May 2022 and 31 May 2023. Each participant underwent second- or third-trimester ultrasound assessment with SonoCNS measurements obtained from two separately acquired volumes (a1, a2) for BPD, HC, OFD, cisterna magna (CM), lateral ventricular atrial width (Vp), and transverse cerebellar diameter (Cereb). Primary endpoints (full set: BPD/HC/OFD/CM/Vp/Cereb) were persistent AI failure (the same parameter missing in both acquisitions for at least one of the six parameters) and AI instability (missing ≥1 parameter in ≥1 acquisition). Structure-specific models assessed miss_CM, miss_Vp, and miss_Cereb. Logistic regression adjusted for operator, fetal presentation, gravidity/parity, and GA-adjusted fetal size residual z-scores (EFW-, HC-, and BPD-for-GA); sensitivity analyses were restricted to AZZ and to examinations at p < 0.001). In multivariable models, the corresponding adjusted ORs were 9.61 (95% CI 4.55–20.28), 9.62 (4.57–20.27), and 21.29 (10.25–44.22), respectively (all p < 0.001). These associations persisted in AZZ-only analyses. Examinations performed by JM were associated with lower CM/Cereb instability and persistent failure, although operator comparisons were limited by the absence of JM examinations at ≥28 weeks. Conclusions: Missing SonoCNS outputs were common across two acquisitions. Later gestational age was associated with greater output instability, particularly for lateral ventricular atrial width, but not with persistent failure after adjustment. Operator-associated differences were observed for selected endpoints; however, their interpretation is limited by the unequal gestational age distribution and the absence of objective acquisition-quality assessment.
- Open Access
- 19 October 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (10) , 2392
Decision Limits for Fetal Speckle-Tracking Outputs: Minimal Detectable Change and Threshold Instability in FetalHQ
Background: Fetal Heart Quantification (FetalHQ) enables detailed assessment of fetal cardiac morphology and function using two-dimensional speckle-tracking echocardiography. However, previous studies have focused primarily on conventional reproducibility metrics such as the intraclass correlation coefficient (ICC). From a clinical perspective, it is more relevant to determine what magnitude of change exceeds measurement noise and whether a single result may lead to unstable classification relative to normative thresholds. The aim of this study was to evaluate the decision limits of selected FetalHQ parameters, including the minimal detectable change (MDC95), threshold instability, and the theoretical effect of averaging two independent analyses. Materials and Methods: This methodological study included 93 paired analyses (_1 and _2) obtained from the same recorded four-chamber cine loop under the assumption of zero biological variability. The intra-operator subset (n = 34) and inter-operator subset (n = 59) were analyzed separately. For key parameters, we determined the proportion of usable pairs after quality filtering, bias, Bland–Altman 95% limits of agreement, MDC95, classification flip rates for normalized outputs, and the width of the uncertainty zone (grey zone) around diagnostic thresholds. In addition, we estimated the effect of a mean-of-two workflow on measurement error reduction. Results: The best analytical performance was observed for left ventricular volumetric parameters, particularly LV EDV and LV ESV, which showed the highest proportion of usable pairs (88.2–94.9%) and relatively low MDC95 values. Functional and deformation metrics performed substantially worse, including LV EF, LV FRAC, LV GLS, and RV TAPSE, all of which were characterized by lower usability and wider limits of agreement, especially in the inter-operator analysis. Classification instability was greatest for normalized parameters. In the inter-operator analysis, classification flips occurred in 33.3% of cases for LV EF centile 2. Under the theoretical assumption of independent random measurement error, the estimated MDC95 for the mean of two analyses was approximately 29% lower than that for a single analysis; this reduction was mathematically derived rather than prospectively observed. Conclusions: FetalHQ showed the highest analytical stability for simpler LV volumetric parameters, whereas functional and deformation outputs remained substantially more susceptible to measurement noise and classification instability, particularly between operators. In practice, this means that a single measurement obtained near normative thresholds may be insufficient for reliable interpretation. A theoretical mean-of-two approach may reduce random measurement uncertainty, but this strategy was not prospectively validated and does not overcome the limitations of the least analytically stable parameters.
- 19 October 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (10) , 2392
Open AccessDecision Limits for Fetal Speckle-Tracking Outputs: Minimal Detectable Change and Threshold Instability in FetalHQ
Background: Fetal Heart Quantification (FetalHQ) enables detailed assessment of fetal cardiac morphology and function using two-dimensional speckle-tracking echocardiography. However, previous studies have focused primarily on conventional reproducibility metrics such as the intraclass correlation coefficient (ICC). From a clinical perspective, it is more relevant to determine what magnitude of change exceeds measurement noise and whether a single result may lead to unstable classification relative to normative thresholds. The aim of this study was to evaluate the decision limits of selected FetalHQ parameters, including the minimal detectable change (MDC95), threshold instability, and the theoretical effect of averaging two independent analyses. Materials and Methods: This methodological study included 93 paired analyses (_1 and _2) obtained from the same recorded four-chamber cine loop under the assumption of zero biological variability. The intra-operator subset (n = 34) and inter-operator subset (n = 59) were analyzed separately. For key parameters, we determined the proportion of usable pairs after quality filtering, bias, Bland–Altman 95% limits of agreement, MDC95, classification flip rates for normalized outputs, and the width of the uncertainty zone (grey zone) around diagnostic thresholds. In addition, we estimated the effect of a mean-of-two workflow on measurement error reduction. Results: The best analytical performance was observed for left ventricular volumetric parameters, particularly LV EDV and LV ESV, which showed the highest proportion of usable pairs (88.2–94.9%) and relatively low MDC95 values. Functional and deformation metrics performed substantially worse, including LV EF, LV FRAC, LV GLS, and RV TAPSE, all of which were characterized by lower usability and wider limits of agreement, especially in the inter-operator analysis. Classification instability was greatest for normalized parameters. In the inter-operator analysis, classification flips occurred in 33.3% of cases for LV EF centile 2. Under the theoretical assumption of independent random measurement error, the estimated MDC95 for the mean of two analyses was approximately 29% lower than that for a single analysis; this reduction was mathematically derived rather than prospectively observed. Conclusions: FetalHQ showed the highest analytical stability for simpler LV volumetric parameters, whereas functional and deformation outputs remained substantially more susceptible to measurement noise and classification instability, particularly between operators. In practice, this means that a single measurement obtained near normative thresholds may be insufficient for reliable interpretation. A theoretical mean-of-two approach may reduce random measurement uncertainty, but this strategy was not prospectively validated and does not overcome the limitations of the least analytically stable parameters.
- Open Access
- 10 October 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (10) , 2303
Explained and Residual Variability of the Fetal Mechanical PR Interval in Structurally Normal Hearts: A Secondary Analysis of Physiological, Biometric, and Doppler Covariates
Background/Objectives: A previous publication reported that routinely measured covariates explained approximately 10% of fetal mechanical PR interval (mPR) variance. This secondary analysis examined how explanatory information is distributed among correlated predictors, their incremental contributions beyond fetal heart rate (FHR), and performance across alternative model specifications. Methods: We analysed 903 complete cases with normal fetal echocardiographic findings. Predictors comprised FHR, gestational age (GA), biparietal diameter (BPD), fronto-occipital diameter (FOD), pulmonary valve diameter (PVD), and umbilical artery pulsatility index (UA PI). Hierarchical ordinary least squares regression was complemented by general dominance analysis across all 720 predictor entry orders, bootstrap uncertainty estimates, and sensitivity analyses using shared ten-fold outer cross-validation splits. Results: The full-model apparent R2 of 0.0986 was consistent with the previously reported low explanatory capacity. The additional analyses showed that FHR accounted for 51.23% of full-model explained variance in general dominance analysis. Adding GA after FHR increased R2 by 0.0237; subsequent additions of BPD, FOD and PVD, and then UA PI, increased R2 by 0.0061 and 0.0037, respectively (p = 0.112 and p = 0.057). Full-model pooled out-of-fold R2 was 0.0826. Exploratory gradient boosting increased apparent R2 to 0.1722 but yielded a lower out-of-fold R2 of 0.0554. Conclusions: This secondary analysis extends the previous report by quantifying incremental and shared explanatory information and comparing apparent fit with internal validation performance. FHR accounted for the largest average contribution across predictor entry orders, while the additional biometric and Doppler blocks provided limited incremental information after FHR and GA. The evaluated alternative specifications did not substantially improve internal validation performance. The low overall explained variance is consistent with the previous publication and is not a new finding. Model-unexplained variance cannot be attributed specifically to intrinsic atrioventricular conduction properties, because its biological and measurement-related components cannot be distinguished using the available data.
- 10 October 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (10) , 2303
Open AccessExplained and Residual Variability of the Fetal Mechanical PR Interval in Structurally Normal Hearts: A Secondary Analysis of Physiological, Biometric, and Doppler Covariates
Background/Objectives: A previous publication reported that routinely measured covariates explained approximately 10% of fetal mechanical PR interval (mPR) variance. This secondary analysis examined how explanatory information is distributed among correlated predictors, their incremental contributions beyond fetal heart rate (FHR), and performance across alternative model specifications. Methods: We analysed 903 complete cases with normal fetal echocardiographic findings. Predictors comprised FHR, gestational age (GA), biparietal diameter (BPD), fronto-occipital diameter (FOD), pulmonary valve diameter (PVD), and umbilical artery pulsatility index (UA PI). Hierarchical ordinary least squares regression was complemented by general dominance analysis across all 720 predictor entry orders, bootstrap uncertainty estimates, and sensitivity analyses using shared ten-fold outer cross-validation splits. Results: The full-model apparent R2 of 0.0986 was consistent with the previously reported low explanatory capacity. The additional analyses showed that FHR accounted for 51.23% of full-model explained variance in general dominance analysis. Adding GA after FHR increased R2 by 0.0237; subsequent additions of BPD, FOD and PVD, and then UA PI, increased R2 by 0.0061 and 0.0037, respectively (p = 0.112 and p = 0.057). Full-model pooled out-of-fold R2 was 0.0826. Exploratory gradient boosting increased apparent R2 to 0.1722 but yielded a lower out-of-fold R2 of 0.0554. Conclusions: This secondary analysis extends the previous report by quantifying incremental and shared explanatory information and comparing apparent fit with internal validation performance. FHR accounted for the largest average contribution across predictor entry orders, while the additional biometric and Doppler blocks provided limited incremental information after FHR and GA. The evaluated alternative specifications did not substantially improve internal validation performance. The low overall explained variance is consistent with the previous publication and is not a new finding. Model-unexplained variance cannot be attributed specifically to intrinsic atrioventricular conduction properties, because its biological and measurement-related components cannot be distinguished using the available data.
- Open Access
Empirical Antibiotic Initiation for Suspected Early-Onset Neonatal Infection in the Setting of Maternal GBS Screening and Intrapartum Antibiotic Prophylaxis: A Single-Center Retrospective Cohort Study
Background and Objectives: Maternal Group B Streptococcus (GBS) screening and intrapartum antibiotic prophylaxis have reduced early-onset GBS disease. However, suspected early-onset neonatal infection (EONI) remains a broader clinical challenge, as signs prompting empirical antibiotic treatment may also occur in non-infectious disorders of postnatal adaptation. Therefore, this study evaluated the frequency of systemic antibiotic initiation for suspected EONI and the utilization and microbiological yield of blood cultures in a single-center cohort managed with routine maternal GBS screening and intrapartum antibiotic prophylaxis. Materials and Methods: This retrospective cohort study included 2010 mother–newborn dyads delivered between 2019 and 2022. The primary outcome was systemic antibiotic therapy initiated within the first 72 h of life because of suspected EONI. Blood culture utilization and microbiological yield were analyzed separately from the primary treatment outcome. Positive blood culture findings were interpreted descriptively because of the small number of isolates and the possibility of contamination. Results: Empirical systemic antibiotic therapy for suspected EONI was initiated in 71 neonates (3.53%). The observed treatment rates among neonates born to GBS-colonized and non-colonized mothers were 16/402 (3.98%) vs. 55/1608 (3.42%) (RR 1.16, 95% CI 0.67–2.01; p = 0.59). In an exploratory multivariable analysis, the adjusted OR for maternal GBS colonization and antibiotic initiation was 1.33 (95% CI 0.68–2.60; p = 0.408). Lower gestational age was the strongest associated factor. Treated neonates were more frequently preterm and had more respiratory disorders, NICU admissions, pPROM, and lower Apgar scores. Blood cultures were obtained in 79 neonates, including 63 treated for suspected EONI. Nine sampled neonates had positive blood cultures, including seven treated neonates; several isolates were compatible with contamination. No GBS isolates were detected among the sampled neonates. Conclusions: Empirical systemic antibiotics were initiated for suspected EONI in 3.53% of neonates. This treatment frequency does not estimate early-onset sepsis (EOS) incidence. The study did not detect a statistically significant association between maternal GBS colonization and antibiotic initiation, but the wide confidence intervals do not exclude clinically relevant increases in treatment. Selective blood culture sampling, possible contamination, and incomplete microbiological adjudication preclude reliable estimates of culture-confirmed EOS incidence or pathogen distribution.
Open AccessEmpirical Antibiotic Initiation for Suspected Early-Onset Neonatal Infection in the Setting of Maternal GBS Screening and Intrapartum Antibiotic Prophylaxis: A Single-Center Retrospective Cohort Study
Background and Objectives: Maternal Group B Streptococcus (GBS) screening and intrapartum antibiotic prophylaxis have reduced early-onset GBS disease. However, suspected early-onset neonatal infection (EONI) remains a broader clinical challenge, as signs prompting empirical antibiotic treatment may also occur in non-infectious disorders of postnatal adaptation. Therefore, this study evaluated the frequency of systemic antibiotic initiation for suspected EONI and the utilization and microbiological yield of blood cultures in a single-center cohort managed with routine maternal GBS screening and intrapartum antibiotic prophylaxis. Materials and Methods: This retrospective cohort study included 2010 mother–newborn dyads delivered between 2019 and 2022. The primary outcome was systemic antibiotic therapy initiated within the first 72 h of life because of suspected EONI. Blood culture utilization and microbiological yield were analyzed separately from the primary treatment outcome. Positive blood culture findings were interpreted descriptively because of the small number of isolates and the possibility of contamination. Results: Empirical systemic antibiotic therapy for suspected EONI was initiated in 71 neonates (3.53%). The observed treatment rates among neonates born to GBS-colonized and non-colonized mothers were 16/402 (3.98%) vs. 55/1608 (3.42%) (RR 1.16, 95% CI 0.67–2.01; p = 0.59). In an exploratory multivariable analysis, the adjusted OR for maternal GBS colonization and antibiotic initiation was 1.33 (95% CI 0.68–2.60; p = 0.408). Lower gestational age was the strongest associated factor. Treated neonates were more frequently preterm and had more respiratory disorders, NICU admissions, pPROM, and lower Apgar scores. Blood cultures were obtained in 79 neonates, including 63 treated for suspected EONI. Nine sampled neonates had positive blood cultures, including seven treated neonates; several isolates were compatible with contamination. No GBS isolates were detected among the sampled neonates. Conclusions: Empirical systemic antibiotics were initiated for suspected EONI in 3.53% of neonates. This treatment frequency does not estimate early-onset sepsis (EOS) incidence. The study did not detect a statistically significant association between maternal GBS colonization and antibiotic initiation, but the wide confidence intervals do not exclude clinically relevant increases in treatment. Selective blood culture sampling, possible contamination, and incomplete microbiological adjudication preclude reliable estimates of culture-confirmed EOS incidence or pathogen distribution.
- Top Cited PapersOpen Access
- 28 July 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (15) , 5891
Neonatal Respiratory Outcomes in Placenta Previa with Histopathologically Confirmed Placenta Accreta Spectrum
Background and Objectives: Placenta accreta spectrum (PAS) complicating placenta praevia is associated with increased maternal morbidity; however, neonatal respiratory burden may be underappreciated. We compared neonatal outcomes between pregnancies complicated by placenta praevia with and without histopathologically confirmed PAS, with additional adjustment of respiratory outcomes for gestational age at delivery. Materials and Methods: We conducted a retrospective single-centre cohort study (n = 82). Based on placental histopathology, women were classified as PAS (n = 37; accreta/increta/percreta) or non-PAS (n = 45). Respiratory endpoints included respiratory resuscitation at birth, non-invasive respiratory support, and supplemental oxygen requirement with fraction of inspired oxygen (FiO2) > 0.21 during neonatal intensive care unit (NICU) hospitalization. Logistic regression models adjusted respiratory endpoints for gestational age. Results: Data were available for 80/82 neonates. Compared with non-PAS, PAS cases had higher rates of respiratory resuscitation at birth (26/36 [72.2%] vs. 19/44 [43.2%], p = 0.013), non-invasive respiratory support (31/36 [86.1%] vs. 24/44 [54.5%], p = 0.003), and supplemental oxygen requirement (29/36 [80.6%] vs. 21/44 [47.7%], p = 0.003). After adjustment for gestational age, PAS remained associated with respiratory resuscitation (adjusted odds ratio [aOR] 3.34, 95% confidence interval [CI] 1.21–9.27; p = 0.020) and supplemental oxygen requirement (aOR 4.60, 95% CI 1.35–15.75; p = 0.015). The association with non-invasive respiratory support did not reach statistical significance (aOR 4.46, 95% CI 0.92–21.68; p = 0.064). Conclusions: Histopathologically confirmed PAS was associated with higher neonatal respiratory support requirements after adjustment for gestational age, supporting anticipatory obstetric–neonatal planning when PAS is suspected.
- 28 July 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (15) , 5891
Top Cited PapersOpen AccessNeonatal Respiratory Outcomes in Placenta Previa with Histopathologically Confirmed Placenta Accreta Spectrum
Background and Objectives: Placenta accreta spectrum (PAS) complicating placenta praevia is associated with increased maternal morbidity; however, neonatal respiratory burden may be underappreciated. We compared neonatal outcomes between pregnancies complicated by placenta praevia with and without histopathologically confirmed PAS, with additional adjustment of respiratory outcomes for gestational age at delivery. Materials and Methods: We conducted a retrospective single-centre cohort study (n = 82). Based on placental histopathology, women were classified as PAS (n = 37; accreta/increta/percreta) or non-PAS (n = 45). Respiratory endpoints included respiratory resuscitation at birth, non-invasive respiratory support, and supplemental oxygen requirement with fraction of inspired oxygen (FiO2) > 0.21 during neonatal intensive care unit (NICU) hospitalization. Logistic regression models adjusted respiratory endpoints for gestational age. Results: Data were available for 80/82 neonates. Compared with non-PAS, PAS cases had higher rates of respiratory resuscitation at birth (26/36 [72.2%] vs. 19/44 [43.2%], p = 0.013), non-invasive respiratory support (31/36 [86.1%] vs. 24/44 [54.5%], p = 0.003), and supplemental oxygen requirement (29/36 [80.6%] vs. 21/44 [47.7%], p = 0.003). After adjustment for gestational age, PAS remained associated with respiratory resuscitation (adjusted odds ratio [aOR] 3.34, 95% confidence interval [CI] 1.21–9.27; p = 0.020) and supplemental oxygen requirement (aOR 4.60, 95% CI 1.35–15.75; p = 0.015). The association with non-invasive respiratory support did not reach statistical significance (aOR 4.46, 95% CI 0.92–21.68; p = 0.064). Conclusions: Histopathologically confirmed PAS was associated with higher neonatal respiratory support requirements after adjustment for gestational age, supporting anticipatory obstetric–neonatal planning when PAS is suspected.
- Open Access
- 24 March 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (7) , 2469
Reply to DeVore, G.R. Determination of the Same Cardiac Cycle When Analyzing Cine Clips for Use by FetalHQ to Assess Intraobserver and Interobserver Variability. Comment on “Mlodawski et al. Reproducibility Challenges in Fetal Cardiac Function Analysis with 2D Speckle-Tracking Echocardiography: Insights from FetalHQ. J. Clin. Med. 2025, 14, 3301”
- 24 March 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (7) , 2469
Open AccessReply to DeVore, G.R. Determination of the Same Cardiac Cycle When Analyzing Cine Clips for Use by FetalHQ to Assess Intraobserver and Interobserver Variability. Comment on “Mlodawski et al. Reproducibility Challenges in Fetal Cardiac Function Analysis with 2D Speckle-Tracking Echocardiography: Insights from FetalHQ. J. Clin. Med. 2025, 14, 3301”
- Open Access
- 23 October 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (21) , 7522
Physiological Determinants of PR Interval in Healthy Fetuses: Insights from Correlation and Regression Modeling
Background: The fetal mechanical PR interval (mPR), measured using pulsed-wave Doppler, is a widely used parameter to assess atrioventricular conduction in fetuses, particularly in cases at risk of developing atrioventricular (AV) block. However, the physiological factors that influence mPR readings are not fully understood. This study aimed to identify determinants affecting the measurement of the mPR interval using the mitral valve/aorta (MV/Ao) Doppler method in a cohort of structurally normal fetuses. Methods: We retrospectively analyzed 925 fetuses with normal echocardiographic findings and no structural cardiac or extracardiac anomalies. Correlation analysis, group comparisons, trend testing, and multivariable modeling were performed to assess the impact of biometric and Doppler parameters on mPR interval measurements. Results: The median mPR interval across the cohort was 116 ms (interquartile range: 108–123 ms). Fetuses were categorized into four gestational age groups (≤19 weeks, 20–23 weeks, 24–27 weeks, and ≥28 weeks). Significant differences in mPR were observed between gestational age groups (p < 0.01), with a positive trend across increasing gestational age (p < 0.0001). The strongest correlation was an inverse relationship between mPR and fetal heart rate (FHR) (ρ = −0.256, p < 0.01). Multivariable regression identified five independent predictors of mPR: lower FHR, greater biparietal diameter (BPD), larger pulmonary valve diameter (PVD), increased fronto-occipital diameter (FOD), and lower umbilical artery pulsatility index (UA PI). The final model explained approximately 9.9% of the variance in mPR interval (R2 = 0.099). Conclusions: The fetal mPR interval increases with gestational age and is primarily influenced by fetal heart rate, even after adjusting for other factors. Certain biometric and Doppler parameters also contribute modestly to mPR variation. These findings highlight the importance of accounting for physiological variability when interpreting mPR measurements in clinical fetal cardiology.
- 23 October 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (21) , 7522
Open AccessPhysiological Determinants of PR Interval in Healthy Fetuses: Insights from Correlation and Regression Modeling
Background: The fetal mechanical PR interval (mPR), measured using pulsed-wave Doppler, is a widely used parameter to assess atrioventricular conduction in fetuses, particularly in cases at risk of developing atrioventricular (AV) block. However, the physiological factors that influence mPR readings are not fully understood. This study aimed to identify determinants affecting the measurement of the mPR interval using the mitral valve/aorta (MV/Ao) Doppler method in a cohort of structurally normal fetuses. Methods: We retrospectively analyzed 925 fetuses with normal echocardiographic findings and no structural cardiac or extracardiac anomalies. Correlation analysis, group comparisons, trend testing, and multivariable modeling were performed to assess the impact of biometric and Doppler parameters on mPR interval measurements. Results: The median mPR interval across the cohort was 116 ms (interquartile range: 108–123 ms). Fetuses were categorized into four gestational age groups (≤19 weeks, 20–23 weeks, 24–27 weeks, and ≥28 weeks). Significant differences in mPR were observed between gestational age groups (p < 0.01), with a positive trend across increasing gestational age (p < 0.0001). The strongest correlation was an inverse relationship between mPR and fetal heart rate (FHR) (ρ = −0.256, p < 0.01). Multivariable regression identified five independent predictors of mPR: lower FHR, greater biparietal diameter (BPD), larger pulmonary valve diameter (PVD), increased fronto-occipital diameter (FOD), and lower umbilical artery pulsatility index (UA PI). The final model explained approximately 9.9% of the variance in mPR interval (R2 = 0.099). Conclusions: The fetal mPR interval increases with gestational age and is primarily influenced by fetal heart rate, even after adjusting for other factors. Certain biometric and Doppler parameters also contribute modestly to mPR variation. These findings highlight the importance of accounting for physiological variability when interpreting mPR measurements in clinical fetal cardiology.
- Open Access
- 30 September 2025
- Published by International Scientific Information, Inc. in American Journal of Case Reports
- Vol. 26, e948218
Disseminated Peritoneal Leiomyomatosis of the Peritoneum Following Laparoscopic Supracervical Hysterectomy with Morcellation: A Case Report
BACKGROUND Disseminated peritoneal leiomyomatosis is a rare complication of laparoscopic procedures involving uterine morcellation. These fibroid-like lesions, which derive their blood supply from non-uterine sources, may develop after myomectomy, supracervical hysterectomy, or total laparoscopic hysterectomy - particularly when mechanical morcellation is used. Although the incidence is low, disseminated leiomyomatosis should be considered in the differential diagnosis of abdominal or pelvic pain in patients with a history of such surgeries. CASE REPORT A 40-year-old woman presented with intermittent lower abdominal pain. She had undergone a laparoscopic supracervical hysterectomy with salpingectomy 5 years earlier due to abnormal uterine bleeding, during which uncontained mechanical morcellation was performed. At present, transvaginal ultrasound revealed a solid mass adjacent to the bladder with features suggestive of a leiomyoma. Magnetic resonance imaging (MRI) showed multiple lesions, including a polycyclic mass located above the bladder and additional foci near the sigmoid colon and the bladder dome. Laparoscopy confirmed the presence of leiomyomas on the anterior abdominal wall, sigmoid colon adventitia, and bladder dome. All lesions were excised using laparoscopic techniques, and the postoperative course was uneventful. Histopathological examination confirmed leiomyomas with positive estrogen and progesterone receptor expression. CONCLUSIONS This case underscores the importance of considering disseminated peritoneal leiomyomatosis in the differential diagnosis of abdominal or pelvic pain in patients with a history of laparoscopic hysterectomy with morcellation. It also emphasizes that this condition can mimic malignancy on imaging studies and highlights the essential role of histopathological examination in diagnosing this benign disease.
- 30 September 2025
- Published by International Scientific Information, Inc. in American Journal of Case Reports
- Vol. 26, e948218
Open AccessDisseminated Peritoneal Leiomyomatosis of the Peritoneum Following Laparoscopic Supracervical Hysterectomy with Morcellation: A Case Report
BACKGROUND Disseminated peritoneal leiomyomatosis is a rare complication of laparoscopic procedures involving uterine morcellation. These fibroid-like lesions, which derive their blood supply from non-uterine sources, may develop after myomectomy, supracervical hysterectomy, or total laparoscopic hysterectomy - particularly when mechanical morcellation is used. Although the incidence is low, disseminated leiomyomatosis should be considered in the differential diagnosis of abdominal or pelvic pain in patients with a history of such surgeries. CASE REPORT A 40-year-old woman presented with intermittent lower abdominal pain. She had undergone a laparoscopic supracervical hysterectomy with salpingectomy 5 years earlier due to abnormal uterine bleeding, during which uncontained mechanical morcellation was performed. At present, transvaginal ultrasound revealed a solid mass adjacent to the bladder with features suggestive of a leiomyoma. Magnetic resonance imaging (MRI) showed multiple lesions, including a polycyclic mass located above the bladder and additional foci near the sigmoid colon and the bladder dome. Laparoscopy confirmed the presence of leiomyomas on the anterior abdominal wall, sigmoid colon adventitia, and bladder dome. All lesions were excised using laparoscopic techniques, and the postoperative course was uneventful. Histopathological examination confirmed leiomyomas with positive estrogen and progesterone receptor expression. CONCLUSIONS This case underscores the importance of considering disseminated peritoneal leiomyomatosis in the differential diagnosis of abdominal or pelvic pain in patients with a history of laparoscopic hysterectomy with morcellation. It also emphasizes that this condition can mimic malignancy on imaging studies and highlights the essential role of histopathological examination in diagnosing this benign disease.
- Open Access
- 23 September 2025
- Published by VM Media Group sp. z o.o in Ginekologia Polska
- Vol. 97 (1) , 57-61
Indications and findings of fetal echocardiography: a retrospective analysis of a high-risk cohort in a polish center
Objectives: Fetal echocardiography (FE) is a critical diagnostic tool for assessing cardiac and extracardiac abnormalities in high-risk pregnancies. In this paper we evaluate indications and findings of FE in a high-risk cohort at a Polish fetal echocardiography clinic. Material and methods: This retrospective, observational cohort study included 991 patients undergoing FE between January 2023 and December 2024. A single prenatal cardiologist with extensive FE experience performed all examinations. Indications and findings were analyzed, with results categorized into subgroups. Results: Mean maternal age was 31.6 years (SD 5.3), with a median gestational age of 26 weeks (IQR = 4). The most frequent indications were intermediate risk of chromosomal aberrations from first-trimester screening (17.76%), intra-cardiac echogenic foci (13.32%), and elevated risk of chromosomal aberrations (12.82%), comprising 43.69% of referrals. Normal FE results were observed in 88.49% of cases (n = 877). Abnormalities (cardiac or extracardiac) occurred in 11.51%, with cardiac abnormalities in 7.16% (71 cases: 3.12% structural, 4.03% functional). Ventricular septal defect (1%) and arrhythmias (1.31%) were the most common structural and functional findings, respectively. Extracardiac abnormalities with normal cardiac imaging occurred in 4.3%. No significant differences in abnormality prevalence were found between high/intermediate chromosomal risk groups and the cohort (odds ratios: 0.47–1.14). Conclusions: First-trimester screening results and soft markers predominantly drove FE referrals. The 11.51% abnormality rate underscores the importance of FE in high-risk pregnancies, despite no significant association with chromosomal risk levels. Keywords: fetal echocardiography prenatal diagnosis high-risk pregnancy fetal cardiology intracardiac echogenic foci
- 23 September 2025
- Published by VM Media Group sp. z o.o in Ginekologia Polska
- Vol. 97 (1) , 57-61
Open AccessIndications and findings of fetal echocardiography: a retrospective analysis of a high-risk cohort in a polish center
Objectives: Fetal echocardiography (FE) is a critical diagnostic tool for assessing cardiac and extracardiac abnormalities in high-risk pregnancies. In this paper we evaluate indications and findings of FE in a high-risk cohort at a Polish fetal echocardiography clinic. Material and methods: This retrospective, observational cohort study included 991 patients undergoing FE between January 2023 and December 2024. A single prenatal cardiologist with extensive FE experience performed all examinations. Indications and findings were analyzed, with results categorized into subgroups. Results: Mean maternal age was 31.6 years (SD 5.3), with a median gestational age of 26 weeks (IQR = 4). The most frequent indications were intermediate risk of chromosomal aberrations from first-trimester screening (17.76%), intra-cardiac echogenic foci (13.32%), and elevated risk of chromosomal aberrations (12.82%), comprising 43.69% of referrals. Normal FE results were observed in 88.49% of cases (n = 877). Abnormalities (cardiac or extracardiac) occurred in 11.51%, with cardiac abnormalities in 7.16% (71 cases: 3.12% structural, 4.03% functional). Ventricular septal defect (1%) and arrhythmias (1.31%) were the most common structural and functional findings, respectively. Extracardiac abnormalities with normal cardiac imaging occurred in 4.3%. No significant differences in abnormality prevalence were found between high/intermediate chromosomal risk groups and the cohort (odds ratios: 0.47–1.14). Conclusions: First-trimester screening results and soft markers predominantly drove FE referrals. The 11.51% abnormality rate underscores the importance of FE in high-risk pregnancies, despite no significant association with chromosomal risk levels. Keywords: fetal echocardiography prenatal diagnosis high-risk pregnancy fetal cardiology intracardiac echogenic foci
- Open Access
- 15 May 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-11
Reproducibility of quantitative cervical strain elastography in nonpregnant patients and the effect of vaginal misoprostol on measured parameters
Quantitative strain elastography (SE), referred to as E-Cervix (Samsung Medison), is a novel method for assessing parameters that indirectly describe the elasticity of the cervix. This evaluation yields quantitative parameters based on the analysis of the elastographic map image, which represents a new approach in the context of SE. In our study, we aimed to examine the reproducibility of this method in evaluating the cervix of non-pregnant women, the impact of basic demographic parameters of the patient on the results, and the responsiveness of the method, i.e., the assessment of changes occurring in the results after the vaginal application of a 400 µg dose of misoprostol. We included 80 patients scheduled for hysteroscopy who underwent elastographic examination using the E-Cervix module. The examination was performed twice upon admission to the department by the same ultrasonographer and then again 10–12 h after vaginal application of misoprostol, consecutively by two ultrasonographers. Our study demonstrated high reproducibility of all obtained parameters, with ICC (Intraclass Correlation Coefficient) for intraobserver variability being good to excellent, ranging from 0.85 for ECI (Elasticity index) to 0.94 for IOS (Internal Os strain)/EOS (External Os strain) ratio. For interobserver variability, ICC values ranged from 0.76 for ECI to 0.97 for IOS/EOS ratio. We observed no significant correlation between parameters such as height, weight, BMI (body mass index), and the number of births in the patient’s history and the values of elastographic parameters. We found weak to moderate positive correlations between the day of the cycle in which the patient was and ECI (rho = 0.28), EOS (rho = 0.41), IOS/EOS ratio (rho = 0.33). The study observed a significant increase in the median value of the HR (Hardness ratio) parameter after the application of vaginal misoprostol (median difference = 5.32), an increase in EOS (difference of the medians = 0.04), and a significant decrease in IOS/EOS ratio (difference of medians = − 0.05). In our study, we demonstrated high reproducibility and repeatability of E-Cervix parameters in non-pregnant women and showed a negligible influence of most demographic factors on the study outcomes, as well as changes in parameter values under the influence of drugs affecting cervical elasticity. The method appears to be suitable for evaluating the cervix in non-pregnant women.
- 15 May 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-11
Open AccessReproducibility of quantitative cervical strain elastography in nonpregnant patients and the effect of vaginal misoprostol on measured parameters
Quantitative strain elastography (SE), referred to as E-Cervix (Samsung Medison), is a novel method for assessing parameters that indirectly describe the elasticity of the cervix. This evaluation yields quantitative parameters based on the analysis of the elastographic map image, which represents a new approach in the context of SE. In our study, we aimed to examine the reproducibility of this method in evaluating the cervix of non-pregnant women, the impact of basic demographic parameters of the patient on the results, and the responsiveness of the method, i.e., the assessment of changes occurring in the results after the vaginal application of a 400 µg dose of misoprostol. We included 80 patients scheduled for hysteroscopy who underwent elastographic examination using the E-Cervix module. The examination was performed twice upon admission to the department by the same ultrasonographer and then again 10–12 h after vaginal application of misoprostol, consecutively by two ultrasonographers. Our study demonstrated high reproducibility of all obtained parameters, with ICC (Intraclass Correlation Coefficient) for intraobserver variability being good to excellent, ranging from 0.85 for ECI (Elasticity index) to 0.94 for IOS (Internal Os strain)/EOS (External Os strain) ratio. For interobserver variability, ICC values ranged from 0.76 for ECI to 0.97 for IOS/EOS ratio. We observed no significant correlation between parameters such as height, weight, BMI (body mass index), and the number of births in the patient’s history and the values of elastographic parameters. We found weak to moderate positive correlations between the day of the cycle in which the patient was and ECI (rho = 0.28), EOS (rho = 0.41), IOS/EOS ratio (rho = 0.33). The study observed a significant increase in the median value of the HR (Hardness ratio) parameter after the application of vaginal misoprostol (median difference = 5.32), an increase in EOS (difference of the medians = 0.04), and a significant decrease in IOS/EOS ratio (difference of medians = − 0.05). In our study, we demonstrated high reproducibility and repeatability of E-Cervix parameters in non-pregnant women and showed a negligible influence of most demographic factors on the study outcomes, as well as changes in parameter values under the influence of drugs affecting cervical elasticity. The method appears to be suitable for evaluating the cervix in non-pregnant women.